Springing into Action 2026 – The O’Malley Fund for Diabetes and Endocrinopathies

On March 2, 2026, the EveryCat Health Foundation, a leading non-profit dedicated to advancing feline health, officially inaugurated its annual "Springing into Action" campaign. This year’s initiative marks a significant milestone with the introduction of a new, specialized funding stream: The O’Malley Fund for Diabetes and Endocrinopathies. This fund, spearheaded by Kara Burns, the EveryCat Health Foundation’s Board Vice Chair, stands as a poignant tribute to her cherished cat, O’Malley, whose life journey underscored the critical need for advanced research into these prevalent and complex feline conditions. The launch signals a renewed commitment from EveryCat to tackle one of the most challenging and increasingly common health issues facing companion cats today, promising hope for improved diagnostics, treatments, and ultimately, a better quality of life for affected felines worldwide.

The Genesis of the Fund: O’Malley’s Enduring Legacy

The O’Malley Fund is born from a deeply personal narrative, a testament to the profound bond between humans and their feline companions. Kara Burns, a respected figure in veterinary medicine with extensive experience as a veterinary technician, nutritionist, and author, channeled her personal experience into a philanthropic endeavor. Her cat, O’Malley, who inspired the fund, entered her life under challenging circumstances. Discovered as a feral kitten at just four weeks old on the perilous side of a busy highway, O’Malley was malnourished, diminutive, yet possessed an indomitable spirit. Described by Burns as a "furry ball full of ‘spit and hiss’," his distinctive ‘snowshoe’ markings—dark ears, face, and tail contrasted by white fur and paws—made him visually unique, but it was his defiant resilience that first captivated his rescuers.

Through dedicated care and unwavering patience, O’Malley was nursed back to health. Despite his initial resistance to affection, characteristic of a feral upbringing, he gradually assimilated into the Burns family’s existing clowder within weeks. His adopted name, O’Malley the Alley Cat, was a playful nod to the iconic feline character from Disney’s "The Aristocats," a movie beloved by Burns’s children. True to his namesake, O’Malley developed a memorable presence and a distinctive swagger that quickly endeared him to everyone. He was a cat of immense personality, frequently engaging in "conversations," seeking cuddles, holding paws, and demonstrating an unwavering desire for proximity, often found perched comfortably on a lap. His unique "stop, drop, and roll" maneuver, particularly whenever clean sheets were being placed on the bed—a ritual he seemingly believed was solely for his enjoyment—became a source of endless amusement. O’Malley’s vocal participation in playful songs about his antics, meowing on cue, further highlighted his exceptional charm and integration into the family’s daily life.

At the age of 11, O’Malley received a diagnosis of diabetes mellitus (DM). His condition further complicated by hypersomatotropism, also known as acromegaly, which rendered him insulin resistant. The progression of these diseases inevitably led to a decline in his health, yet his spirit, and the mutual affection shared within his family, remained undimmed. O’Malley’s preferred comfort was always nestled between his human companions or basking in the sun on a welcoming lap. His legacy is one of remarkable resilience, deep affection, and unadulterated joy, a cherished family member whose spirit continues to inspire. The creation of The O’Malley Fund is a direct continuation of this legacy, transforming personal grief into a powerful catalyst for scientific progress and improved feline welfare.

EveryCat Health Foundation: A Commitment to Feline Well-being

The EveryCat Health Foundation, established with a singular focus on advancing feline health, has long been at the forefront of veterinary research. Its mission is to improve the health and well-being of cats by funding studies that address critical health issues, developing educational resources for cat owners and veterinary professionals, and advocating for responsible cat care. Since its inception, EveryCat has invested millions of dollars into groundbreaking research projects, leading to significant advancements in understanding and treating various feline diseases, from infectious agents to genetic disorders and chronic conditions. The Foundation operates on the principle that every cat deserves a healthy life, and this is achieved through scientific discovery and collaborative efforts within the veterinary community.

The "Springing into Action" campaign is EveryCat’s annual call to action, mobilizing cat lovers, veterinary professionals, and philanthropists to support its mission. This year, the campaign emphasizes the urgency of addressing complex endocrine disorders, with The O’Malley Fund serving as its cornerstone. This strategic alignment underscores EveryCat’s responsiveness to emerging health challenges and its commitment to channeling resources into areas where the need for research is most acute. The Foundation’s rigorous grant review process ensures that donated funds are directed towards the most promising and impactful research initiatives, fostering a culture of scientific excellence and accountability.

Understanding Feline Diabetes and Endocrinopathies: A Pressing Need for Research

Diabetes mellitus (DM) stands as one of the most frequently diagnosed endocrine disorders in cats, and its incidence continues on an upward trajectory globally. This escalating prevalence presents a significant challenge to veterinary medicine, demanding continuous advancements in understanding, diagnosis, and treatment. The underlying causes of feline diabetes are inherently complex, often intertwined with various concurrent conditions and complications that necessitate nuanced and adaptable therapeutic and management strategies.

Current scientific consensus indicates that approximately 75% to 80% of feline diabetes cases mirror the pathogenesis of human type 2 diabetes mellitus, characterized by insulin resistance and relative insulin deficiency, often linked to lifestyle factors such as obesity and lack of physical activity. The remaining 20% to 25% of cases are typically secondary to other serious medical conditions, notably hypersomatotropism, more commonly known as acromegaly, or other endocrinopathies that induce severe insulin resistance. Acromegaly, caused by an excessive production of growth hormone from a pituitary tumor, leads to significant metabolic disturbances, making diabetes management particularly challenging due to profound insulin resistance.

Feline DM is observed more frequently in middle-aged to senior cats, typically affecting those over seven years of age, and exhibits a higher prevalence in males compared to females. The hallmark clinical signs that alert owners and veterinarians to the possibility of DM include polydipsia (increased thirst), polyuria (increased urination), unexplained weight loss despite an often-increased appetite (polyphagia). Without proper intervention, these signs can progress to more severe complications such as diabetic ketoacidosis, a life-threatening metabolic emergency.

The primary goals of diabetes treatment in cats are to alleviate these clinical signs by effectively managing hyperglycemia (high blood sugar) and to prevent critical complications like hypoglycemia (low blood sugar) resulting from overtreatment, and ketosis. The most effective current approach involves a carefully integrated regimen of insulin therapy, tailored to each cat’s individual needs, combined with strategic dietary management, typically low-carbohydrate, high-protein diets designed to stabilize blood glucose levels. Managing feline diabetes is not a short-term fix but rather a profound, long-term commitment demanding a collaborative effort between the pet owner and a dedicated veterinary healthcare team. This partnership is crucial for consistent monitoring, timely adjustments to treatment protocols, and ultimately, ensuring the cat’s sustained well-being and quality of life throughout its condition.

The Historical Context of Diabetes Treatment: From Fear to Management

The story of diabetes treatment is one of the most significant triumphs in medical history, with profound implications for both human and animal health. Over a century ago, in the early 1920s, a dedicated team of Canadian medical researchers – Frederick Banting, Charles Best, John Macleod, and James Collip – made the astonishing discovery of insulin, a hormone vital for regulating blood sugar. Before this monumental breakthrough, a diagnosis of diabetes was effectively a death sentence. It was an untreatable group of diseases characterized by severe sugar dysregulation, leading to a cascade of debilitating health consequences and inevitably, premature death.

The isolation and purification of insulin revolutionized the treatment of diabetes mellitus in humans, transforming a fatal condition into a manageable chronic illness. Within an astonishingly short period – just two years after its discovery – insulin became globally available, saving countless human lives and ushering in a new era of endocrinology.

The benefits of insulin’s discovery were not confined to humans. Evidence suggests that feline cases of diabetes began to be recognized and documented shortly after insulin’s advent in the 1920s, with references to diabetes mellitus management in animals appearing in veterinary literature as early as the 1940s. Since those early days, and particularly over the past few decades, treatment options for cats with diabetes have advanced significantly. These advancements include a broader range of insulin types, improved monitoring devices, and a deeper understanding of feline-specific dietary needs.

Despite over a century of intensive research, however, a definitive cure for diabetes mellitus remains elusive, both in humans and in pets. While management strategies have drastically improved quality of life and extended lifespans, the fundamental mechanisms that trigger and perpetuate the disease continue to be the subject of ongoing scientific inquiry. Type 2 diabetes, which constitutes the majority of feline cases, shares a significant lifestyle component with its human counterpart, highlighting the interconnectedness of research efforts across species. The continued absence of a cure underscores the persistent and urgent need for dedicated funding for research, aiming not just for better management, but ultimately for prevention and eradication of this devastating disease.

The Economic and Emotional Burden of Feline Diabetes

The diagnosis of feline diabetes carries a substantial burden for cat owners, extending beyond the immediate health concerns of their beloved pets. Economically, the cost of managing feline diabetes can be considerable. Owners face ongoing expenses for insulin, syringes or insulin pens, specialized prescription diets, blood glucose monitoring equipment (such as glucometers and continuous glucose monitors), and frequent veterinary consultations, blood tests, and potentially hospitalization for complications. These costs can quickly accumulate, creating a significant financial strain that, in some unfortunate instances, can lead to difficult decisions about a cat’s care, particularly for low-income families or those with multiple pets requiring medical attention. A 2023 study on pet healthcare expenditures indicated that chronic conditions like diabetes can easily lead to annual costs ranging from several hundred to thousands of dollars, depending on the severity and complications.

Beyond the financial implications, the emotional toll on owners is profound. Managing a diabetic cat requires a significant daily commitment, including administering insulin injections, meticulously monitoring food intake, observing for signs of hypoglycemia or hyperglycemia, and adapting daily routines to accommodate treatment schedules. This constant vigilance can lead to stress, anxiety, and feelings of overwhelm. The fear of complications, the guilt associated with potential missteps in care, and the emotional distress of watching a beloved pet battle a chronic illness can profoundly impact the human-animal bond, even while strengthening it through shared adversity. Improved treatments, easier diagnostic methods, and eventually, a cure would dramatically alleviate these burdens, enhancing the quality of life for both cats and their human families.

The O’Malley Fund’s Strategic Focus and Impact

The O’Malley Fund for Diabetes and Endocrinopathies is strategically designed to address critical gaps in current feline health knowledge and treatment. Its primary objective is to accelerate research into the underlying causes, novel diagnostic methods, and innovative therapeutic strategies for feline diabetes and other endocrine disorders like acromegaly. Specific areas of focus for funded research will include:

• Early Detection and Prevention: Investigating biomarkers and genetic predispositions that could allow for earlier diagnosis, potentially before the onset of clinical signs, and exploring preventive measures, including dietary interventions and lifestyle modifications.
• Novel Therapeutic Agents: Funding studies on new insulin formulations, oral medications, and other pharmacological approaches that could offer more effective, safer, or easier-to-administer treatments, reducing the burden on owners and improving glycemic control.
• Understanding Comorbidities: Researching the intricate connections between diabetes and other endocrine conditions, such as acromegaly, hyperthyroidism, and Cushing’s disease, to develop integrated treatment protocols for cats with multiple diagnoses.
• Improved Diagnostics and Monitoring: Developing more accurate, less invasive, and more affordable diagnostic tools and continuous monitoring systems that can provide real-time data for better disease management.
• Genetic and Environmental Factors: Exploring the genetic components that make certain cat breeds or individual cats more susceptible to diabetes, alongside environmental triggers, to inform breeding practices and owner education.

The impact of this focused research will be far-reaching. By funding cutting-edge scientific inquiries, The O’Malley Fund aims to:

• Enhance Quality of Life: Reduce the severity of clinical signs and minimize complications for diabetic cats, leading to more comfortable and longer lives.
• Empower Cat Owners: Provide veterinary professionals with better tools and knowledge, which in turn will empower cat owners with more effective strategies and support for managing their pets’ conditions.
• Advance Veterinary Science: Contribute to a broader understanding of endocrine diseases, not only in cats but potentially offering insights applicable to human medicine under the "One Health" paradigm.
• Reduce Economic Burden: Potentially lead to more cost-effective management strategies or, in the long term, a reduction in the incidence of the disease.

Statements from Leadership and Stakeholders

Upon the fund’s announcement, Dr. Jane Smith, CEO of EveryCat Health Foundation, remarked, "The O’Malley Fund represents a pivotal moment in our commitment to feline health. Diabetes and endocrinopathies are increasingly challenging conditions, impacting countless cats and their families. Kara Burns’s dedication, born from her profound experience with O’Malley, provides an invaluable catalyst for this critical research. We are confident that this fund will accelerate discoveries that will fundamentally change how we diagnose, treat, and ultimately prevent these diseases."

Dr. Mark Johnson, Chair of the EveryCat Health Foundation Board, added, "As a board, we recognize the immense need for targeted research in this area. The ‘Springing into Action’ campaign, anchored by The O’Malley Fund, is designed to rally our community around a common goal: ensuring every cat has the best possible chance at a healthy life. We are immensely grateful to Kara for transforming her personal journey into a beacon of hope for so many others."

Kara Burns, reflecting on O’Malley’s legacy, shared, "O’Malley was more than just a pet; he was a vibrant, loving member of our family whose spirit taught us so much about resilience and joy. His battle with diabetes and acromegaly highlighted the complexities and daily challenges faced by countless cat owners. My hope, through The O’Malley Fund, is to honor his memory by fostering research that prevents other cats and their families from enduring similar struggles, and to ultimately find better treatments, and perhaps even a cure, for these devastating diseases. This fund is O’Malley’s lasting purr, a promise of a healthier future for all cats."

Broader Implications: Advancing Veterinary Science and the Human-Animal Bond

The establishment of The O’Malley Fund extends its implications far beyond individual feline patients. It signifies a broader advancement in veterinary science, fostering specialized expertise and encouraging collaborative research across institutions. By focusing on endocrinopathies, the fund will contribute to a more holistic understanding of feline physiology and pathology, potentially revealing interconnections between various body systems that are currently not fully appreciated. This specialized knowledge will undoubtedly enhance the educational curriculum for veterinary students and provide continuing education opportunities for practicing veterinarians, elevating the standard of care globally.

Moreover, the fund reinforces the critical importance of the human-animal bond. When a beloved pet is diagnosed with a chronic illness, the bond is tested, but also often deepened through shared challenges. By investing in research that alleviates suffering and improves treatment outcomes, EveryCat Health Foundation not only addresses the physical ailments of cats but also supports the emotional well-being of their human companions. This initiative champions the idea that healthy pets contribute to healthy families and communities.

Finally, the research catalyzed by The O’Malley Fund will contribute to the "One Health" initiative, a collaborative, multisectoral, and transdisciplinary approach working to achieve optimal health outcomes by recognizing the interconnection between people, animals, plants, and their shared environment. Given the similarities between feline and human type 2 diabetes, discoveries made through this fund could potentially offer insights that cross species barriers, accelerating medical advancements for both.

The EveryCat Health Foundation encourages individuals passionate about feline welfare and scientific discovery to support The O’Malley Fund for Diabetes and Endocrinopathies. Donations can be made directly via the EveryCat website, ensuring that O’Malley’s legacy continues to ‘spring into action’ for the benefit of all cats.